Tag: neurovascular

Biomodex launches synthetic clot product for neurovascular training

Biomodex, a company specialising in biorealistic haptic simulators for physician training and rehearsals, has announced the launch of Thrombotech—a new, hydrogel-based synthetic clot product...
imperative zoom trial

Imperative Care enrols first patient in trial evaluating Zoom 88 Large...

Imperative Care has announced that the first patient has been enrolled in the Imperative trial. This prospective, multicentre clinical trial is the first study...
neurovasc envi-sr trial china

NeuroVasc announces enrolment of first patient in ENVI-SR mechanical thrombectomy system...

NeuroVasc Technologies has announced that the first patient has been treated in a pivotal randomised controlled trial (RCT) in China, which will evaluate the...
Medtronic receives CE mark approval for radial artery access portfolio

Medtronic receives CE mark approval for radial artery access portfolio

Medtronic today announced it has received CE mark approval for its radial artery access portfolio, which includes the Rist radial access selective catheter and the Rist...
medtronic pipeline flex recall

Medtronic recalls Pipeline Flex embolisation devices over risk of delivery system...

Medtronic has issued a recall of its Pipeline Flex embolisation device and Pipeline Flex embolisation device with Shield technology products due to a risk...
phenox longer stentriever

Phenox highlights benefits of longer stentriever devices with new study results

Following its acceptance into Frontiers in Neurology, Phenox has announced the results of a paper exploring the benefit of choosing a longer stentriever for...
carotid disease stenting

Treatment of asymptomatic carotid bifurcation occlusive disease and potential role of...

Peter A Schneider (San Francisco, USA) discusses the role stenting can play, alongside the existing best medical therapy, in treating asymptomatic carotid disease patients. Best...
hemo bioengineering afentta

HeMo Bioengineering receives China’s NMPA approval for Afentta aspiration catheter

HeMo Bioengineering, a Singapore-based medical device company with a focus on treating stroke patients, has announced that its Afentta intracranial thrombectomy aspiration catheter—a product...
vesalio

Vesalio initiates new FDA stroke study following “milestone” VITAL trial enrolment

US medical device company Vesalio has announced the start of enrolment in the Vesalio CLEAR study—an acute ischaemic stroke FDA investigational device exemption (IDE)...
CereVasc eShunt system

CereVasc gains financing to support eShunt system to treat hydrocephalus

CereVasc, a company focused on the treatment of patients with hydrocephalus, announced the closing of an expanded Series A financing that raised US$43.9 million....
021 Contour Cerus endovascular

Cerus Endovascular’s 021 Contour neurovascular system approved in Europe

Cerus Endovascular has received CE Mark approval for its 0.021-inch Contour neurovascular system, compatible with smaller commercially available 021 microcatheters for the treatment of...

Enrolment completed early for Rapid Medical’s TIGER study for thrombectomy device

Rapid Medical has announced that it has completed enrolment in the TIGER (Treatment with Intent to generate reperfusion) study ahead of the planned scheduled....
diffusion pharmaceuticals

Diffusion Pharmaceuticals anticipates coronavirus will slow enrolment in its ambulance-based stroke...

Diffusion Pharmaceuticals has announced that it expect delays in enrolment in the company’s ambulance-based PHAST-TSC phase 2 clinical trial in acute stroke due to...
Artio Medical study

Artio Medical announces interim study results highlighting aneurysm occlusion device

Artio Medical has announced the recent presentation of interim nonclinical study results at the ABC-WIN Seminar in Val d'Isere, France. Presented by Blaise Baxter,...
cerus endovascular contour

Cerus Endovascular receives CE mark approval for its Contour Neurovascular System...

Cerus Endovascular has received CE mark approval for its lead product, the Contour Neurovascular System, for the treatment of intracranial aneurysms. The system incorporates...
imperative care financing series C

Imperative Care announces appointment of Brian Armijo as vice president of...

Imperative Care has announced that Brian Armijo has been appointed as vice president of operations. With more than 25 years of manufacturing and operations...
CorPath GRX Corindus

Corindus announces regulatory approval of CorPath GRX for neurovascular intervention in...

Corindus Vascular Robotics has announced that it received approval from the Australian Therapeutic Goods Administration to commercialise its CorPath GRX System for neurovascular interventions...

Vesalio reports expansion of international distributor network and Stroke Congress Exhibition...

Vesalio has announced that it has executed multiple exclusive distribution agreements in Europe, Latin America, Asia and the Middle East and now has market...

Physicians’ Education Resource to host first annual International Congress on the...

Physicians’ Education Resource (PER), a worldwide leading resource for continuing medical education (CME), will host the first annual International Congress on the Future of...

Corindus announces FDA submission for neurovascular intervention indication for CorPath GRX

Corindus Vascular Robotics announces that it is seeking premarket clearance from the US Food and Drug Administration (FDA) to use the CorPath GRX System...

Are drug-coated balloons and drug-eluting stents the future in intracranial atherosclerotic...

Alternative treatment options for patients with intracranial atherosclerotic disease (ICAD) are needed, given its prevalence worldwide and the associated risk of recurrent ischaemic events....

Favourable revascularisation rates for first-in-man results of the Versi Retriever in...

First-in-man results of the Versi Retriever (NeuroVasc Technologies) in acute ischaemic stroke patients with large vessel occlusions demonstrate a promising safety profile and efficacious...

Cerenovus launches largest global registry to study stroke-inducing blood clots removed...

Johnson & Johnson has announced that its Cerenovus business has launched the single largest global registry, the EXCELLENT Registry, to collect and analyse stroke-inducing...